Friday, December 14, 2007
Plenary Speech 1-3
| Moderator: | Volker Schachinger (Germany) |
| 08:30-09:00 | Clinical Experiences in Autologous Stem Cell Therapy for End Stage Heart Diseases Damras Tresukosol (Thailand) |
| Moderator: | Shu-Hsun Chu (Taiwan) |
| 09:00-09:30 | New Trends in Cardiac Surgical Education in the United States Fredrick A. Crawford Jr. (USA) |
| Moderator: | Delon Wu (Taiwan) |
| 09:30-10:00 | Ionic and Molecular Mechanisms of Atrial Fibrillation Stanley Nattel (Canada) |
S1-EP: GENETIC MECHANISMS OF CARDIAC ARRHYTHMIAS
| Moderators: | Shoei K. Stephen Huang (USA) Mau-Song Chang (Taiwan) |
| 10:30-10:52 | Genetics of Sudden Unexplained Death Syndrome in Southeast Asia Somkiat Sangwatanaroj (Thailand) |
| 10:52-11:14 | Genetics of Congenital Long QT syndrome and Brugada syndrome in Japan Wataru Shimizu (Japan) |
| 11:14-11:36 | Genetics of Clinical Atrial Fibrillation in Taiwan Ling-Ping Lai (Taiwan) |
| 11:36-11:58 | Altered Intracellular Calcium Handling Phenotypes in Atrial Fibrillation Yung-Hsin Yeh (Taiwan) |
S2-EP: UPDATES IN ELECTROPHYSIOLOGY AND CATHER ABLATION OF ATRIAL FIBRILLATION
| Moderators: | Wen-Ter Lai (Taiwan) |
| 14:00-14:15 | Electrophysiologic Mechanism of Atrial Fibrillation: from Bench to Bedside Stanley Nattel (Canada) |
| 14:15-14:30 | Atrial Ectopic Triggers as the Target in Catheter Ablation of Atrial Fibrillation Young-Hoon Kim (Korea) |
| 14:30-14:45 | Atrial Substrate as the Target in Catheter Ablation of Atrial Fibrillation Shih-Ann Chen (Taiwan) |
| 14:45-15:00 | Registration of Atrial Fibrillation Catheter Ablation Hung-Fat Tse (Hong Kong) |
| 15:00-15:15 | Changes and Challenges in the Treatment of Atrial Fibrillation Shoei K. Stephen Huang (USA) |
| 15:15-15:30 | Panel Discussion |
S3-EP: TRANSCATHETER INTERVENTIONAL THERAPY OF VENTRICULAR TACHYARRHYTHMIA
| Moderators: | Hung-Fat Tse (Hong Kong) Jiunn-Lee Lin (Taiwan) |
| 16:00-16:22 | Catheter Ablation of Idiopathic Ventricular Tachycardia in Normal Heart Ming-Shien Wen (Taiwan) |
| 16:22-16:44 | Catheter Ablation of Ventricular Tachycardia Associated with Prior Myocardial infarct Using CARTOTM Mapping Kyoko Soejima (Japan) |
| 16:44-17:06 | Catheter Ablation of Ventricular Tachyarrhythmias Post-Myocardial Infarction by Noncontact EnsiteTM Mapping Paolo Della Bella (Italy) |
| 17:06-17:28 | Sudden Death Syndrome in Asia: Prevalence and Management Kathy Lee (Hong Kong) |
S4-CAD: THE MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION
| Moderators: | Abdullah Shafi Majumder (Bangladesh) Shyh-Ming Shieh (Taiwan) |
| 10:30-10:45 | Medical Therapy for Acute Myocardial Infarction Jaw-Wen Chen (Taiwan) |
| 10:45-11:00 | Glycoprotein IIb/IIIa Inhibitors in Acute Myocardial Infarction Huay Cheem Tan (Singapore) |
| 11:00-11:15 | Update on Interventional Therapy for STEMI Harry Suryapranata (The Netherlands) |
| 11:15-11:30 | Japanese Stable Angina Pectoris (JSAP) Study: A Randomized Comparative Multi-Center Study between PCI-Medical and Medical-Preceding Therapies Hisayoshi Fujiwara (Japan) |
| 11:30-11:45 | The Role of Surgery in Acute Myocardial Infarction Shoei-Shen Wang (Taiwan) |
| 11:45-12:00 | Panel Discussion |
S5-CAD: THE DETECTION AND MANAGEMENT OF ACUTE CORONARY SYNDROME
| Moderators: | Richard Ng (Singapore) Yuan-Teh Lee (Taiwan) Chung-Yin Chen (Taiwan) |
| 14:00-14:15 | Pathology of Vulnerable Plaque Renu Virmani (USA) |
| 14:15-14:30 | Initiation and Pathogenesis of Acute Coronary Syndrome – Angioscopic Evaluation of ACS Culprit Lesions, Vulnerable Plaques and Vulnerable Patients Yasunori Ueda (Japan) |
| 14:30-14:45 | Optimal Treatment of Acute Coronary Syndrome John V. Amerena (Australia) |
| 14:45-15:00 | Transcatheter Intervention for Acute Coronary Syndrome Anil Kumar (India) |
| 15:00-15:15 | PET/CT for Vulnerable Atherosclerotic Plaque Imaging Yen-Wen Wu (Taiwan) |
| 15:15-15:30 | Panel Discussion |
S7-Pha: HDL-CHOLESTEROL IN THE TREATMENT OF ATHEROSCLEROSIS
| Moderators: | Antonio S. Sibulo (Philippines) Ming-Fong Chen (Taiwan) |
| 10:30-10:52 | Targeting Cholesterol Ester Transfer Protein for the Prevention and Management of Cardiovascular Disease Philip Barter (Australia) |
| 10:52-11:14 | TSOC: Nong Ting Award: Lecture TBA (Taiwan) |
| 11:14-11:36 | TSOC: Young Investigator Award: Lecture TBA (Taiwan) |
| 11:36-11:58 | HDL Cholesterol and Atherosclerosis: Insights from Population Science Kuo-Liong Chien (Taiwan) |
S8-Joint APSC/WHF: TOBACCO CONTROL
| Moderators: | TBA Wen-Pin Lien (Taiwan) |
| 14:00-14:17 | Effective Tobacco Strategies – Indian Experience Srinath Reddy (India) |
| 14:17-14:34 | FCTC Global Implications and Strategies Elinor Wilson (Canada) |
| 14:34-14:51 | Tobacco Use in Youth and Its Control in Asian Pacific Region Mrigendra Raj Pandey (Nepal) |
| 14:51-15:08 | Perceptional Differences towards Smoking and Smoking Cessation between Physicians and Smokers in Asia: Analysis from 16-Nation Global Surveys Chi-Pang Wen (Taiwan) |
| 15:08-15:30 | Panel Discussion |
S9-Joint APSC/WHF: EPIDEMIOLOGY
| Moderators: | TBA |
| 16:00-16:17 | Secondary Prevention Strategies Sidney Smith (USA) |
| 16:17-16:34 | BRIG Project China Implementation of Guidelines Dong Zhao (China) |
| 16:34-16:51 | Secondary Prevention of Heart Failure Mario Maranhao (Brazil) |
| 16:51-17:08 | TBA TBA |
| 17:08-17:30 | Panel Discussion |
S10-Ped: CARDIAC CHILDREN IN ASIAN-PACIFIC REGION
| Moderators: | Indriwanto S. Atmosudigdo (Indonesia) Hung-Chi Lue (Taiwan) Wen-Jen Su (Taiwan) |
| 10:30-10:45 | Cardiac Children in Asian-Pacific Region: North Asia and Pacific Mei-Hwan Wu (Taiwan) |
| 10:45-11:00 | Cardiac Children in Asian-Pacific Region: Mainland China Yong-Hao Gui (China) |
| 11:00-11:15 | Cardiac Children in Asian-Pacific Region: South-East Asia Edgardo E. Ortiz (Philippines) |
| 11:15-11:30 | Cardiac Children in Asian-Pacific Region: South Asia and Middle East Krishna S. Iyer (India) |
| 11:30-11:45 | Rheumatic Fever: 6 Decades after Jones Criteria Edward L. Kaplan (USA) |
| 11:45-12:00 | Panel Discussion |
S11-Ped:ARRHYTHMIAS AND IMAGING IN CHILDREN
| Moderators: | Wataru Shimizu (Japan) Jiunn-Ren Wu (Taiwan) |
| 14:00-14:22 | Latest Echocardiographic Technologies for Assessing Myocardial Function in the Child and the Fetus Azaria Rein (Israel) |
| 14:22-14:44 | Channelopathy as a Cause of Sudden Cardiac Death in Children Wataru Shimizu (Japan) |
| 14:44-15:06 | New Techniques of Mapping and Ablation for Tachyarrhythmias in Children Ming-Lon Young (USA) |
| 15:06-15:28 | Device Therapy in Children Anne M. Dubin (USA) |
S13-Basic: VASCULAR BIOLOGY
| Moderators: | Kenneth Ng (Singapore) Yi-Heng Li (Taiwan) |
| 10:30-10:52 | Pathways Regulating Smooth Muscle Cell Proliferation Andrew Newby (UK) |
| 10:52-11:14 | Endothelial Progenitor Cells for Vascular Medicine Takayuki Asahara (Japan) |
| 11:14-11:36 | Regulation of Endothelial Connexins during Atherogenesis Hung-I Yeh (Taiwan) |
| 11:36-11:58 | Role of Myostatin in the Cardiovascular System Kou-Gi Shyu (Taiwan) |
S14-Joint APSC/ESC: STEM CELL THERAPY FOR CARDIOVASCULAR DISEASES
| Moderators: | Michal Tendera (Poland) Damras Tresukosol (Thailand) |
| 14:00-14:25 | Does the Heart Have a Potential to Regenerate? Michal Tendera (Poland) |
| 14:25-14:50 | Stem Cell Therapy in Acute Myocardial Infarction, the European Experience Volker Schachinger (Germany) |
| 14:50-15:15 | Stem Cell Therapy in Acute Myocardial Infarction, the Asian Experience Hyo-Soo Kim (Korea) |
S15-Joint APSC/ESC: STEM CELL THERAPY FOR CARDIOVASCULAR DISEASES
| Moderators: | Michal Tendera (Poland) Damras Tresukosol (Thailand) |
| 15:45-16:10 | Stem Cell Therapy in Other Cardiovascular Diseases Kenneth Ng (Singapore) |
| 16:10-16:35 | Drawbacks of Stem Cell Therapy Chao-Hung Wang (Taiwan) |
| 16:35-17:00 | Future Prospective: Emerging Horizon of Cardiac Engineering Keiichi Fukuda (Japan) |
| 17:00-17:30 | Panel Discussion |
Saturday, December 15, 2007
Plenary Speech 4-6
| Moderator: | Benjamin N. Chiang (Taiwan) |
| 08:30-09:00 | Metalloproteinases and Vulnerable Atherosclerotic Plaques Andrew Newby (UK) |
| Moderator: | Chi-Ren Hung (Taiwan) |
| 09:00-09:30 | Advances in Aortic Surgery Scott Mitchell (USA) |
| Moderator: | Seung-Jung Park (Korea) |
| 09:30-10:00 | Current Status in the Use of Drug-Eluting Stents Alan C. Yeung (USA) |
S16-CRT: DEVICE THERAPY FOR DRUG-REFRACTORY CONGESTIVE HEART FAILURE
| Moderators: | Wee-Siong Teo (Singapore) San-Jou Yeh (Taiwan) Chun-Chieh Wang (Taiwan) |
| 10:30-10:52 | Morphological and Topological Characteristics of Coronary Venous System in Chronic Systolic Heart Failure Wen-Jeng Lee (Taiwan) |
| 10:52-11:14 | Selection of Potential Candidates for Cardiac Resynchronization Therapy of Drug-Refractory Congestive Heart Failure Cheuk-Man Yu (Hong Kong) |
| 11:14-11:36 | Management of Repetitive Shocks from Implanted Cardioverter-Defibrillators in Ischemic and Non-ischemic Cardiomyopathy Paolo Della Bella (Italy) |
| 11:36-11:58 | Atrial Fibrillation Burden in Chronic Heart Failure: the Role of Cardiac Resynchronization Therapy Razali Omar (Malaysia) |
S19-Surgery: SURGERY OF ACQUIRED HEART DISEASES
| Moderators: | Chuen Neng Lee (Singapore) Kwok-Kei Cheng (Taiwan) |
| 10:30-10:52 | Ventricular Assist for Heart Failure Kyung Sun (Korea) |
| 10:52-11:14 | Surgical Ventricular Restoration for Endstage Ischemic Cardiomyopathy Hisayoshi Suma (Japan) |
| 11:14-11:36 | ECMO Support Wen-Je Ko (Taiwan) |
| 11:36-11:58 | Heart Transplantation Jeng Wei (Taiwan) |
S22-HypertensionCRT: HYPERTENSION
| Moderators: | Prabash C. Manoria (India) Yung-Zu Tseng (Taiwan) Yeo-Shin Hwang (Taiwan) |
| 10:30-10:52 | Hypertension, One or Several Guidelines: Does It Matter? Claude Lenfant (USA) |
| 10:52-11:14 | Recent Progress in Molecular Basis of Essential Hypertension Toshio Ogihara (Japan) |
| 11:14-11:36 | A Multi-State Model for Hypertension Hsiu-Hsi Chen (Taiwan) |
| 11:36-11:58 | Clinical Relevance of Central Hemodynamics in Hypertension Chen-Huan Chen (Taiwan) |
S23-Imaging: ECHOCARDIOGRAPHY: TISSUE CHARACTERISTICS & STRAIN SPECKLE
| Moderators: | Tahir Tak (USA) Ying-Tsung Chen (Taiwan) |
| 14:00-14:15 | History of Diastology in Doppler-Echocardiography Akira Kitabatake (Japan) |
| 14:15-14:30 | Re-Assessment of Global Systolic Function in “Diastolic Heart Failure” Chuwa Tei (Japan) |
| 14:30-14:45 | Non-Invasive Assessment of Cardiac Haemodynamics Chander V. Vanjani (India) |
| 14:45-15:00 | Pulsed Wave Tissue Doppler Imaging Evaluation of Left Ventricular Systolic Function Fen-Chiung Lin (Taiwan) |
| 15:00-15:15 | The Role of Echocardiography in Atrial FibrilLation Chun-Li Wang (Taiwan) |
| 15:15-15:30 | Panel Discussion |
S25-Ped: ARRHYTHMIAS IN CHILDREN
| Moderators: | Krishna S. Iyer (India) Ching-Tsuen Shen (Taiwan) Kai-Sheng Hsieh (Taiwan) |
| 10:30-10:45 | Pediatric Echocardiography: Past Tracks and Future Perspectives David J. Sahn (USA) |
| 10:45-11:00 | Percutaneous Pulmonary Valve Implantation Using the Edwards Sapien Transcatheter Heart Valve Ziyad M. Hijazi (USA) |
| 11:00-11:15 | Patent Ductus Arteriosus (PDA) Stenting as Alternative to Blalock Taussig (BT) Shunt–Case selection, Technique and Outcome Mazeni Alwi (Malaysia) |
| 11:15-11:30 | Real Time Transesophagial 3D Echocardiography Guidance of Transcatheter Device Closure ASD Qi-Ling Cao (USA) |
| 11:30-11:45 | TEE In Perioperative Period of Congenital Heart Diseases in Children Guo-Ying Huang (China) |
| 11:45-12:00 | Panel Discussion |
S26-Ped: ADULT CONGENITAL HEART DISEASE
| Moderators: | Teiji Akagi (Japan) Chung-Chang Laura Meng (Taiwan) |
| 14:00-14:22 | Risk Startification for Adult Congenital Heart Disease Makoto Nakazawa (Japan) |
| 14:22-14:44 | Left Ventricular Function in Complex Congenital Heart Disease David J. Sahn (USA) |
| 14:44-15:06 | Pregnancy in Grown-Up Congenital Heart Disease Teiji Akagi (Japan) |
| 15:06-15:28 | Progress in Repair of Atrioventricular Septal Defects Fredrick A. Crawford Jr. (USA) |
S28-Basic:Molecular Research of Cardiovascular Disease
| Moderators: | Kensuke Egashira (Japan) Fu-Tien Chiang (Taiwan) |
| 10:30-10:52 | The Genetic Architecture of Congenital Heart Disease Patrick Y. Jay (USA) |
| 10:52-11:14 | Impact of Nanotechnology-Based Drug Delivery System (NanoDDS) for Treatment of Cardiovasculalr Disease Kensuke Egashira (Japan) |
| 11:14-11:36 | Advances in Molecular Pathology and Therapy for Hypertensive Cardiovascular Disease Hui Yao Lan (Hong Kong) |
| 11:36-11:58 | Warfarin Dosage Requirement Based on Pharmacogenetics Jin-Jer Chen (Taiwan) |
Sunday, December 16, 2007
Plenary Speech 7-9
| Moderator: | Tetsu Yamaguchi (Japan) |
| 08:30-09:00 | Drug-Eluting Stent Pathology: Clinical and Preclinical Studies Renu Virmani (USA) |
| Moderator: | Akira Takeshita (Japan) |
| 09:00-09:30 | Myocarditis and Related Disorders in Asia Akira Matsumori (Japan) |
| Moderator: | Shahryar A. Sheikh (Pakistan) |
| 09:30-10:00 | Epidemiology and Prevention of Cardiovascular Diseases in Asia-Pacific Region Chien-Jen Chen (Taiwan) |
S31-Surgery: SURGERY OF CONGENITAL HEART DISEASES
| Moderators: | Pradistchai Chaiseri (Thailand) Chao-Hsiung Chang (Taiwan) |
| 10:30-10:45 | Norwood Procedure for Hypoplastic Left Heart Syndrome Thomas L. Spray (USA) |
| 10:45-11:00 | Prevention of Heart Block in Complex Congenital Heart Surgery Hiromi Kurosawa (Japan) |
| 11:00-11:15 | Applying New Hybrid Therapies for the Management of Congenital Heart Disease Sheng-Shou Hu (China) |
| 11:15-11:30 | Mechanical Circulatory Support in Children Yih-Sharng Chen (Taiwan) |
| 11:30-11:45 | Surgery in Complex Congenital Heart Disease Shunji Sano (Japan) |
| 11:45-12:00 | Panel Discussion |
S34-CAD: ADVANCES IN THE TRANS-CATHETER TREATMENT OF CAD
| Moderators: | Feridoun Noohi (Iran) Pei-Liang Kuan (Taiwan) |
| 10:30-10:45 | What’s New for Chronic Total Occlusion in 2008? Osamu Katoh (Japan) |
| 10:45-11:00 | TBA Tian Hai Koh (Singapore) |
| 11:00-11:15 | The Polymerfree Drug Eluting Stent: Technology, Evidence and Prospective Jiangtao Yu (Germany) |
| 11:15-11:30 | Management of Restenosis after Drug Eluting Stent Junbo Ge (China) |
| 11:30-11:45 | Drug-Eluting Stent In Diabetic Patient I-Chang Hsieh (Taiwan) |
| 11:45-12:00 | Panel Discussion |
S37-General: RECENT ADVANCE IN NOVEL BIO-MOLECULES FOR CARDIOVASCULAR DISEASE
| Moderators: | Jae Hyung Kim (Korea) Shing-Jong Lin (Taiwan) |
| 10:30-10:52 | C-Reactive Protein in Atherosclerosis Subodh Verma (Canada) |
| 10:52-11:14 | Angiopoietin-Like Proteins (Angptls): Potential New Targets for Metabolic Syndrome Therapy Yuichi Oike (Japan) |
| 11:14-11:36 | Placental Growth Factor in Acute Myocardial Infarction Shiro Uemura (Japan) |
| 11:36-11:58 | Adhesion Molecules in Congestive Heart Failure Wei-Hsian Yin (Taiwan) |
S38-Joint APSC/ACC: APPLICATIONS AND LIMITATIONS OF NEW CORONARY IMAGING METHODS
| Moderators: | Michael Lim (Singapore) TBA |
| 14:00-14:25 | Applications and Limitations of Gray Scale IVUS TBA |
| 14:25-14:50 | Applications and Limitations of Virtual Histology TBA |
| 14:50-15:15 | Applications and Limitations of MSCT Gilbert L. Raff (USA) |
S39-Joint APSC/ACC: APPLICATIONS AND LIMITATIONS OF NEW CORONARY IMAGING METHODS
| Moderators: | Cheng-Wen Chiang (Taiwan) TBA |
| 15:45-16:10 | New Coronary Imaging Methods for Chronic Total Occlusion Intervention Masahiko Ochiai (Japan) |
| 16:10-16:35 | Prudent Use of New Coronary Imaging Methods in the Real World - American Viewpoint TBA |
| 16:35-17:00 | Prudent Use of New Coronary Imaging Methods in the Real World - Asian Viewpoint Kui Hian Sim (Malaysia) |
| 17:00-17:30 | Panel Discussion |
S40-Diastolic Heart Failure: DIASTOLIC HEART FAILURE
| Moderators: | Byung-Hee Oh (Korea) Hisayoshi Fujiwara (Japan) Chung-Sheng Lin (Taiwan) |
| 10:30-10:45 | Clinical Evaluation and Progression of Diastolic Heart Failure Peter P. Liu (Canada) |
| 10:45-11:00 | Echocardiographic Evaluation of Diastolic Function James D. Thomas (USA) |
| 11:00-11:15 | Stabilization of Calcium Release Channel (Ryanodine Receptor) as a New Therapeutic Strategy against Heart Failure Masunori Matsuzaki (Japan) |
| 11:15-11:30 | Heart Failure and Intercellular Connection Chau-Chung Wu (Taiwan) |
| 11:30-11:45 | Current and Future Treatment Options in Heart Failure with Preserved Systolic Function John McMurray (UK) |
| 11:45-12:00 | Panel Discussion |
S41-Ima
| Moderators: | Akira Yamashina (Japan) Morgan Mao-Young Fu (Taiwan) |
| 14:00-14:22 | TBA TBA |
| 14:22-14:44 | Advances of Three-Dimensional Echocardiography in Clinical Practice Junichi Yoshikawa (Japan) |
| 14:44-15:06 | TBA TBA |
| 15:06-15:28 | Three-Dimensional Echocardiography: Current Status and Future Directions Tsui-Lieh Hsu (Taiwan) |
S43-Pulmonary Hypertension: PULMONARY ARTERIAL HYPERTENSION
| Moderators: | Simon Gibbs (UK) Chuen-Den Tseng (Taiwan) |
| 10:30-10:52 | TBA Eugene Kotlyar (Australia) |
| 10:52-11:14 | Health System of Pulmonary Arterial Hypertension in UK: the Practicalities of Managing Pulmonary Arterial Hypertension within a Health Care System Simon Gibbs (UK) |
| 11:14-11:36 | Echocardiography and Cardiac Catheterization in the Evaluation of Patients with Pulmonary Arterial Hypertension James Yip (Singapore) |
| 11:36-11:58 | Experience of Pulmonary Hypertension Treatment in NTUH Yung-Chie Lee (Taiwan) Hsao-Hsun Hsu (Taiwan) |
S44-Valvular Heart Disease: VALVULAR HEART DISEASE
| Moderators: | Pham Gia Khai (Vietnam) Wen-Jin Cherng (Taiwan) Juey-Jen Hwang (Taiwan) |
| 14:00-14:22 | Percutaneous Aortic Valve Deployment Eberhard Grube (Germany) |
| 14:22-14:44 | Cell-Based Mechanism of Myocardial Hypertrophy and Heart Failure due to Aortic Stenosis - Can We Prevent It? Masafumi Kitakaze (Japan) |
| 14:44-15:06 | Percutaneous Valve Intervention for Valvular Heart Disease Jui-Sung Hung (Taiwan) |
| 15:06-15:28 | Management of Functional Mitral Regurgitation – Medical or Surgical Treatment? Muhammad Munawar (Indonesia) |
Satellite Symposium
Venue: Taipei International Convention CenterFriday, December 14 12:00-14:00
| Main Venue: 2F, International Lounge, TICC Host: Bayer Taiwan Ltd. |
|
| WHERE DO WE STAND WITH CARDIOVASCULAR RISK MANAGEMENT? | |
| Moderator: | Shing-Jong Lin (Taiwan) & Wayne H-H Sheu (Taiwan) |
| 12:00-12:05 | Welcome and opening remarks |
| 12:05-12:30 | Advancing cardiovascular risk reduction with Aspirin Carlo Patrono (Italy) |
| 12:30-12:55 | Combined antihypertensive therapy with a CCB – achieving target blood pressure and reducing CV risk Peter Meredith (UK) |
| 12:55- 13:20 | Acarbose in prediabetes and beyond – an ideal treatment for dysglycaemia with cardiovascular benefits Jean-Louis Chiasson (Canada) |
| 13:20- 13:30 | Summary & closing remarks |
| Main Venue: 3F Banquet Hall, TICC Host: Pfizer Taiwan Inc. |
|
| GLOBAL IMPACT OF TOTAL RISK: RECOGNISING THE INTERACTION OF CV RISK FACTORS IN CLINICAL PRACTICE AND APPLYING TREATMENT STRATEGIES | |
| Moderator: | Fu-Tien Chiang (Taiwan) & Wen-Ter Lai (Taiwan) |
| 12:00 | Registration |
| 12:10 | Opening Remarks Fu-Tien Chiang (Taiwan) |
| 12:20 | A decade of statin therapy - where do we stand today? Leif Erhardt (Sweden) |
| 13:00 | The Benefits of Combined Lowering of Blood Pressure and Lipids Byran Williams (UK) |
| 13:40 | Panel Discussion |
| 13:50 | Closing Remarks Wen-Ter Lai (Taiwan) |
| Main Venue: 3F, North Lounge, TICC Host: Johnson & Johnson |
|
| Main Venue: 3F, South Lounge, TICC Host: Abbott Laboratories Services Corp. Taiwan Branch |
|
| ABBOTT VASCULAR LUNCHEON SYMPOSIUM -- RECENT ADVANCES IN NEXT GENERATION DRUG ELUTING STENT | |
| Moderator: | Dr. Wan-Leong Chan (Taiwan) & Dr. Paul H. Chen (Taiwan) |
| 12:05-12:10 | Welcome message |
| 12:10-12:40 | Role of Drug-eluting stents verus Cobalt Alloy Stents in the Real World Practice Hon Kan Yip (Taiwan) |
| 12:40-12:45 | Q & A |
| 12:45-13:15 | Next General DES: Why Xience V is my stent of choice Duncan Ho (Hong Kong) |
| 13:15-13:20 | Q & A |
| 13:20-13:50 | The Science of DES Safety – Latest Findings from Pre-Clinical Data Renu Virmani (USA) |
| 13:50-13:55 | Q & A |
| 13:55-14:00 | Panel discussion and closing |
| Main Venue: 4F, VIP Hall A, TICC Host: AstraZeneca Taiwan Limited |
|
| Safe and effective treatment for diabetic dyslipidaemia James Shepherd (UK) |
|
| The need to target both LDL and HDL to prevent atherosclerosis Philip Barter (Australia) |
|
Friday, December 14 12:00-14:00
| KEEP ONE STEP AHEAD | |
| Main Venue: 1F Room 105, TICC Host: Philips |
|
| The Clinical Application of Real Time 3D TEE Dr. Chi-Ling Cao (U.S.A.) |
|
| Clinical Use of Rotational Coronary Angiography and 3D Modeling Dr. Chi-Jen Tseng (Taiwan) |
|
| New Imaging Developments in Cardiac Catheterization Mr. Niels Melman (Hong Kong) |
|
| Main Venue: 2F Room 202, TICC Host: Servier Taiwan |
|
| NEW ADVANCE IN THE MANAGEMENT OF DIABETIC HYPERTENSION AND ISCHEMIC HEART DISEASE | |
| Moderator: | Jaw-Wen Chen (Taiwan) & Fu-Tien Chiang (Taiwan) |
| 12:15-12:20 | Opening Jaw-Wen Chen (Taiwan) |
| 12:20-12:50 | Improving the prognosis of type 2 diabetes: what does ADVANCE study tell us? Anushka Patel (Australia) |
| 12:50-13:20 | Ivabradine, the first unique and selective If current inhibitor: therapeutic applications in ischemic heart disease. Michal Tendera (Poland) |
| 13:20-13:40 | Discussion |
| 13:40-13:45 | Closing Fu-Tien Chiang (Taiwan) |
| Main Venue: 3F Banquet Hall, TICC Host: Sanofi-aventis Taiwan Co., Ltd. |
|
| EMERGING EPIDEMICS OF 21ST CENTURY: CARDIOMETABOLIC RISK AND HEART FAILURE WITH PRESERVED SYSTOLIC FUNCTION | |
| Moderator: | Shing-Jong Lin (Taiwan) & Chuen-Den Tseng (Taiwan) |
| Abdominal Obesity and Cardiometabolic Risk-New therapies Peter Lansberg (UK) |
|
| Diagnosis and Management of Heart Failure with Preserved Systolic Function John Amerena (Australia) |
|
| Main Venue: 3F South Lounge, TICC Host: Pfizer Taiwan Inc. |
|
| SMOKING CESSATION AND CVD | |
| Moderator: | Christopher Bullen (New Zealand) |
| 11:30 | Registration |
| 12:00 | Opening Remarks Christopher Bullen (New Zealand) |
| 12: 10 | Tobacco Smoking and Cardiovascular Risk Christopher Bullen (New Zealand) |
| 12:40 | The Science of Tobacco Dependence Hayden McRobbie (New Zealand) |
| 13:10 | Pharmacotherapy for Successful Smoking Cessation Serena Tonstad (Norway) |
| 13:40 | Panel Discussion |
| 13:50 | Closing Remarks Christopher Bullen (New Zealand) |
| Main Venue: 3F North Lounge, TICC Host: Medtronic-Mediland (Taiwan) Ltd. |
|
| DESIGN FOR LIFE | |
| Moderator: | Chiung-Jen Wu (Taiwan) |
| Panelist: | Jun-Jack Cheng (Taiwan) |
| 12:00-12:20 | Endeavor Resolute Rosli Mohd Ali |
| 12:20-12:30 | Q&A |
| 12:30-13:10 | The clinical outcome of Endeavor IV and safety analysis of Endeavor pooled data Alan C. Yeung |
| 13:10-13:20 | Q&A |
| 13:20-13:40 | Endeavor Sprint Robaayah Zambahari |
| 13:40-13:50 | Q&A |
| Main Venue: 4F, VIP Hall, TICC Host: Takeda Chemical Industries (Taiwan), Ltd. |
|
| GETTING TO THE HEART OF THE CARDIOVASCULAR CONTINUUM | |
| Moderator: | Chuen-Den Tseng (Taiwan) & John McMurray (UK) |
| 12:00-12:20 | Registration & Lunch |
| 12:20-12:25 | Opening Remarks Chuen-Den Tseng (Taiwan) |
| 12:20-12:55 | Optimizing the use of candesartan in the management of Chronic Heart Failure John McMurray (UK) |
| 12:55-13:20 | How to Approach Chronic Heart Failure? Masafumi Kitakaze (Japan) |
| 13:20-13:45 | The Challenges of Heart Failure Treatment: Today and Tomorrow Akira Matsumori (Japan) |
| 13:45-13:55 | Clinical Disusiion |
| 13:55-14:00 | Closing Remarks John McMurray (UK) |
Sunday, December 16 13:00-14:00
| Main Venue: 1F Room 105, TICC Host: Vasomedical Sole Agent |
|
| TREATMENT OF HEART DISEASE IN ENHANCED EXTERNAL COUNTERPULSATION | |
| Moderator: | Chen-Huan Chen (Taiwan) |
| 12:00~12:10 | Opening Prof. Chen-Huan Chen (Taiwan) |
| 12:10~13:00 | EECP Therapy : “Clinical Update and Mechanistic Insights” Prof. Gregory W. Barsness(America) |
| Moderator | Prof. Chen-Huan Chen (Taiwan) |
| 13:05~13:20 | EECP in the improvement of ventricular function Associate Prof. Chii-Ming Lee (Taiwan) |
| 13:20~13:35 | Enhanced External Counterpulsation for ischemic heart disease – improvement in functional class and life quality Dr. Ching-Fen Wu (Taiwan) |
| 13:35~12:50 | Role of EECP in post courage trial era Dr. Huei-Fong Hung(Taiwan) |
| 13:50~13:55 | Panel Discussion |
| 13:55~14:00 | Closing |
| Main Venue: 2F Room 202, TICC Host: AstraZeneca Taiwan Limited |
|
| WHEN IS ASPIRIN WORTH THE RISK? | |
| Moderator: | Jaw-Town Lin (Taiwan) & Jaw-Wen Chen (Taiwan) |
| 13:00-13:10 | Opening Jaw-Town Lin (Taiwan) |
| 13:10:-13:30 | When is aspirin worth the risk? Francis KL Chan (Hong Kong) |
| 13:30-13:50 | Panel discussion Jaw-Wen Chen (Taiwan) |
| 13:50-14:00 | Free discussion and closing Jaw-Wen Chen (Taiwan) |
| Main Venue: 3F South Lounge, TICC Host: Actelion Pharmaceuticals Ltd. |
|
| CLINICAL EXPERIENCE OF PAH WITH ERA | |
| Moderator: | Yung-Chie Lee (Taiwan) & Jui-Sung Hung (Taiwan) |
| The practicalities in evaluating for PAH Simon Gibbs (UK) |
|
| Medical therapy for PAH: What makes the difference for your patients? Eugene Kotlyer (Australia) |
|
| Main Venue: 3F North Lounge, TICC Host: Medtronic-Mediland (Taiwan) Ltd. |
|
| DES V.S. BMS AND PRACTICAL TECHNIQUES OF COMPLEX LESIONS IN NEW TCI ERA | |
| Moderator: | Hsien-Li Kao (Taiwan) |
| Panelist: | Wen-Lieng Lee (Taiwan) & Yu-Lin Ko (Taiwan) |
| 13:00-13:20 | The outcomes of Drug-Eluting compared to Bare-Metal Stent in Chang-Gun Memorial Hospital Kaohsiung Yuan-Kai Hsieh (Taiwan) |
| 13:20-13:30 | Q&A |
| 13:30-13:50 | Practical techniques for complex lesions Chi-Jen Chang (Taiwan) |
| 13:50-14:00 | Q&A |
| Main Venue: 4F, VIP Hall, TICC Host: sanofi-aventis Taiwan Co., Ltd. |
|
| EXTENDED DURATION OF DUAL ANTIPLATELET THERAPY: WHO AND HOW LONG | |
| Moderator: | Fu-Tien Chiang (Taiwan) |
| Extended Duration of Dual Antiplatelet Therapy: Who and How long John Amerena (Australia) |
|
Friday, December 14 12:00-14:00
| Main Venue: 33F, Room AB, TWTCC Host: Daiichi Sankyo Co., Ltd. |
|
| BLOOD PRESSURE AND BEYOND- ANCILLARY EFFECTS BY ANGIOTENSIN TYPE 1-RECEPTOR BLOCKADE | |
| Chairperson: | Ming-Fong Chen (Taiwan) & Chung- Sheng Lin (Taiwan) |
| Moderator: | Shih-Ping Yang (Taiwan) & Chuen-Den Tseng (Taiwan) |
| 12:00-12:30 | Reception |
| 12:30-12:40 | Opening Remark Ming-Fong Chen (Taiwan) |
| 12:40-13:10 | Angiotensin receptor blockers: Pleiotropic actions and organ protection beyond blood pressure reduction Thomas Unger (Germany) |
| 13:10-13:40 | The Importance of Tight BP Control in Reducing CV events Chern-En Chiang (Taiwan) |
| 13:40 | Panel Discussion & Closing Chung- Sheng Lin (Taiwan) |
| Main Venue: 33F, Room C, TWTCC Host: Novartis (Taiwan) Co., Ltd. |
|
| FROM A-A+: FUTURE CONSIDERATION FOR TREATMENT OF CARDIOVASCULAR CONTINUUM | |
| Moderator: | San-Jou, Yeh (Taiwan) & Wen-Jin Cherng (Taiwan) |
| 12:00-12:30 | Welcome reception and Lunch |
| 12:30-12:35 | Opening San-Jou, Yeh (Taiwan) |
| 12:35-13:15 | Direct Renin Inhibition in Treatment of Hypertension:Blocking the RAS at the Point of Activation Alan Gradman (USA) |
| 13:15-13:55 | Direct Renin Inhibitor:Clinical data so far Chen-Huan Chen (Taiwan) |
| 13:55 -14:00 | Q & A; Closing Wen-Jin Cherng (Taiwan) |
Venue: Taipei World Trade Center Club
Saturday, December 15 12:00-14:00
| Main Venue: 33F, Room AB, TWTCC Host: Merck, Schering-Plough |
|
| THE BRIDGE TO ACHIEVING THE GREATER LDL-C GOAL: INHIBITING CHOLESTEROL ABSORPTION AND PRODUCTION | |
| Moderator: | Delon Wu (Taiwan) |
| Is LDL-C Treatment Goal of <70mg/dL Reasonable & Achievable Goal for at risk Patients with CHD/DM? Peter Yan (Singapore) |
|
| Understanding Lipoproteins in Atherogenesis and the Role of Cholesterol Absorption Szilard Voros (USA) |
|
| What’s the VYTAL Option to Manage Dyslipidemia Today? Mats Eriksson (Sweden) |
|
| Q & A Delon Wu (Taiwan) |
|
| Main Venue: 33F, Room C, TWTCC Host: Novartis (Taiwan) Co., Ltd. |
|
| FROM A-A+: FUTURE CONSIDERATION FOR TREATMENT OF CARDIOVASCULAR CONTINUUM | |
| Moderator: | Wen-Jone Chen (Taiwan) & Ming-Fong Chen (Taiwan) |
| 12:00-12:30 | Welcome reception and Lunch |
| 12:35-13:15 | Paradigm Shift in Hypertension Treatment: From Titration to Combination Chern-En Chiang (Taiwan) |
| 13:15-13:55 | Providing End-Organ protection with RAS Inhibition: The Evidence so far Matthew Weir (USA) |
| 13:55 -14:00 | Q & A; Closing Ming-Fong Chen (Taiwan) |
Venue: Taipei World Trade Center Club
Sunday, December 16 13:00-14:00
| Main Venue: 33F, Room C, TWTCC Host: Merck & Co., Inc. (Taiwan) |
|
| AN EVOLUTION IN MANAGEMENT OF DIABETES AND DYSLIPIDEMIA | |
| Moderator: | Ming-Fong Chen (Taiwan) |
| 13:00-13:05 | Introduction |
| 13:05-13:25 | Treating dyslipidemia beyond LDL Greg Brown (USA) |
| 13:25-13:30 | Q & A |
| 13:30-13:50 | New Avenues in Treatment of T2DM: the Role of DPP-4 inhibitor Chii-Min Hwu (Taiwan) |
| 13:50-13:55 | Q & A |
| 13:55-14:00 | Closing Ming-Fong Chen (Taiwan) |
| 14:00-15:00 | Meet the expert: Prof. Brown will be available for questions and discussion |
